Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Apr 15, 2025; 17(4): 102690
Published online Apr 15, 2025. doi: 10.4251/wjgo.v17.i4.102690
Published online Apr 15, 2025. doi: 10.4251/wjgo.v17.i4.102690
Figure 1 Management and treatment protocol for a patient with advanced rectal cancer.
FOLFOX: Oxaliplatin plus 5-fluorouracil; FOLFIRI: Irinotecan plus 5-fluorouracil; PD: Progressive disease; PR: Partial response; OXA: Oxaliplatin.
- Citation: Xiao X, Wang QW, Zhou ZY, Wang LS, Huang P. Precision treatment for human epidermal growth factor receptor 2-amplified advanced rectal cancer: A case report. World J Gastrointest Oncol 2025; 17(4): 102690
- URL: https://www.wjgnet.com/1948-5204/full/v17/i4/102690.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i4.102690